论文部分内容阅读
目的:通过探讨鼻塞式持续气道正压通气(NCPAP)在新生儿肺透明膜病中的呼吸支持作用及其护理。方法:对66例应用NCPAP治疗的新生儿肺透明膜病的临床资料进行回顾性分析。结果:66例患儿中,NCPAP应用天数为3~10天,平均4.6天,应用NCPAP 4小时临床症状完全缓解33例(41.07%),病情改善29例(51.79%),总有效率达92.86%。4例患儿病情较重,于治疗6小时后改为机械通气辅助呼吸。结论:运用NCPAP治疗新生儿肺透明膜病临床效果显著且安全。
Objective: To explore the respiratory support effect and its nursing of nasal obstructive pulmonary ventilation (NCPAP) in neonatal hyaline membrane disease. Methods: The clinical data of 66 cases of neonatal hyaline membrane disease treated with NCPAP were analyzed retrospectively. Results: The NCPAP application days were 3 to 10 days (average 4.6 days) in 66 infants. The clinical symptoms were relieved completely in 33 (41.07%) and improved in 29 (51.79%) patients with NCPAP 4 hours. The total effective rate was 92.86 %. 4 cases of severe illness in children, after 6 hours of treatment to mechanical ventilation assisted breathing. Conclusion: NCPAP treatment of neonatal hyaline membrane disease clinical effect is significant and safe.